Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.65 |
| ▸ | CPT2 | P23786 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HMGCR | P04035 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | BHMT | Q93088 | 3/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5669465 | 0.97 | FFAR1 (0.62) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL20705535 | 0.95 | FFAR1 (0.60) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL2999282 | 0.86 | FFAR1 (0.75) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL12451278 | 0.85 | TDP1 (0.74) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL8087636 | 0.83 | TDP1 (0.78) | FFAR1CPT2TDP1KDM4ETSHR | |
| SCHEMBL12179966 | 0.82 | FFAR1 (0.62) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL22748728 | 0.81 | TDP1 (0.83) | FFAR1CPT2TDP1TSHRALDH1A1 | |
| SCHEMBL5878804 | 0.81 | TDP1 (0.83) | FFAR1CPT2TDP1TSHRALDH1A1 | |
| SCHEMBL22748689 | 0.81 | TDP1 (0.83) | FFAR1CPT2TDP1TSHRALDH1A1 | |
| SCHEMBL1873452 | 0.81 | TDP1 (0.83) | FFAR1CPT2TDP1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320174-A1 | SPIN ON METAL-ORGANIC FORMULATIONS | MERCK PATENTS GMBH (DE) | 2025-10-16 | — | — | US | claimed |
| EP-4334252-A2 | SPIN ON METAL-ORGANIC FORMULATIONS | Merck Patent GmbH (DE) | 2024-03-13 | — | — | EP | claimed |
| CN-117295693-A | Spin-on metal-organic formulations | 默克专利股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| WO-2022233919-A2 | SPIN ON METAL-ORGANIC FORMULATIONS | MERCK PATENT GMBH (DE) | 2022-11-10 | — | — | WO | claimed |
| CN-109952360-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device | 东友精细化工有限公司 | 2022-03-22 | — | — | CN | claimed |
| US-20110003767-A1 | Inhibitors of Acetyl-CoA Carboxylase for Treatment of Neuronal Hypometabolism | NEUERA PHARMACEUTICALS, INC. (US) | 2011-01-06 | — | — | US | claimed |
| US-20100160443-A1 | COMPOUNDS USEFUL FOR TREATING NEUROLOGICAL DISORDERS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2010-06-24 | — | — | US | claimed |
| EP-2150265-A1 | INHIBITORS OF ACETYL-COA CARBOXYLASE FOR TREATMENT OF NEURONAL HYPOMETABOLISM | Neuera Pharmaceuticals, Inc. (US) | 2010-02-10 | — | — | EP | claimed |
| US-20090182048-A1 | Compounds Useful For Treating Neurological Disorders | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2009-07-16 | — | — | US | claimed |
| WO-2008140828-A1 | INHIBITORS OF ACETYL-COA CARBOXYLASE FOR TREATMENT OF NEURONAL HYPOMETABOLISM | ACCERA, INC. (US) | 2008-11-20 | — | — | WO | claimed |
| US-20060004098-A1 | Compounds useful for treating neurological disorders | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-01-05 | — | — | US | claimed |
| EP-1077926-B1 | PROPYLISOPROPYL ACETAMIDE STEREOISOMERS, A METHOD FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RES DEV CO (IL) | 2005-02-23 | — | — | EP | claimed |
| US-20030212131-A1 | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them | BIALER MEIR (IL) | 2003-11-13 | — | — | US | claimed |
| US-6630602-B1 | Racemic propylisopropyl acetic acid and propylisopropyl acetamide and their isomers in their racemic and stereospecific forms, for use in treatment of neurological and psychotic disorders, and affective disorders and to treat | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2003-10-07 | — | — | US | claimed |
| US-6538013-B2 | As a pour-on or spot-on on formulation for controlling parasites such as fleas in warm blooded animals; such as 2,2-dimethylbutyric acid, (1-((6-chloro-pyridin-3-ylmethyl)-ethyl-amino)-2-nitrovinyl)-methyl -carbamoyloxy)-methyl ester | NOVARTIS ANIMAL HEALTH US, INC. | 2003-03-25 | — | — | US | claimed |
| EP-1077926-A1 | PROPYLISOPROPYL ACETIC ACID AND PROPYLISOPROPYL ACETAMIDE STEREOISOMERS, A METHOD FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2001-02-28 | — | — | EP | claimed |
| WO-1999054282-A1 | PROPYLISOPROPYL ACETIC ACID AND PROPYLISOPROPYL ACETAMIDE STEREOISOMERS, A METHOD FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY (IL) | 1999-10-28 | — | — | WO | claimed |
| US-5645634-A | Composition and method for forming Ba1-X Srx Tiy O3 thin films | MITSUBISHI MATERIALS CORPORATION (JP) | 1997-07-08 | — | — | US | claimed |
| JP-57085348-A | — | — | None | — | — | JP | disclosed |
| EP-0007243-A1 | 2-Aryl-1,3-cyclohexanedione compounds and alkali metal salts, ammonium salts and enol esters thereof, composition and method of controlling acarina ectoparasites on warmblooded animals | UNION CARBIDE CORPORATION (US) | 1980-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320174-A1 | SPIN ON METAL-ORGANIC FORMULATIONS | SLC39A11, SLC39A3, SLC39A7 | FFAR1 3654/4885CPT2 419/4885TDP1 2175/4885 |
| US-20030212131-A1 | Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them | ADCYAP1R1, GRIN2A, PTGER1 | FFAR1 195/4885CPT2 2278/4885TDP1 2590/4885 |
| US-20060004098-A1 | Compounds useful for treating neurological disorders | GAP43, CLN6, NLN | FFAR1 3212/4885CPT2 241/4885TDP1 484/4885 |
| US-20090182048-A1 | Compounds Useful For Treating Neurological Disorders | GAP43, CLN6, NLN | FFAR1 3212/4885CPT2 241/4885TDP1 484/4885 |
| US-20100160443-A1 | COMPOUNDS USEFUL FOR TREATING NEUROLOGICAL DISORDERS | GAP43, CLN6, NLN | FFAR1 3212/4885CPT2 241/4885TDP1 484/4885 |
| US-20110003767-A1 | Inhibitors of Acetyl-CoA Carboxylase for Treatment of Neuronal Hypometabolism | ACACA, ACACB, ACAT1 | FFAR1 769/4885CPT2 26/4885TDP1 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.